The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)-Reference-Cited by-同舟云学术

The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

Published:2005-12-05 Issue:3 Volume:37 Page:283-288
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Morabito F,Stelitano C,Luminari S,Mammi C,Marcheselli L,Callea V,Gentile M,Polimeno G,Merli F,Molica S,Gobbi P,Angrilli F,Brugiatelli M,Federico M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705235.pdf

Reference34 articles.

1. Diehl V, Thomas RK, Re D . Part II: Hodgkin's lymphoma – diagnosis and treatment. Lancet Oncol 2004; 5: 19–26.

2. Diehl V, Stein H, Hummel M, Zollinger R, Connors JM . Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease. Hematology (Am Soc Hematol Educ Program) 2003, 225–247.

3. Yung L, Linch D . Hodgkin's lymphoma. Lancet 2003; 361: 943–951.

4. Aisenberg AC . Problems in Hodgkin's disease management. Blood 1999; 93: 761–779.

5. Aparicio J, Segura A, Garcera S, Oltra A, Santaballa A, Yuste A et al. ESHAP is an active regimen for relapsing Hodgkin's disease. Ann Oncol 1999; 10: 593–595.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunochemotherapy of refractory classical Hodgkin's lymphoma with high-dose consolidation and autologous hematopoietic stem cell transplantation complicated by a new coronavirus infection;Oncohematology;2022-07-20

2. ESMO Consensus Conference on malignant lymphoma: management of ‘ultra-high-risk’ patients;Annals of Oncology;2018-08

3. Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma;Biology of Blood and Marrow Transplantation;2017-07

4. Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents;Expert Opinion on Biological Therapy;2016-02-06

5. How I treat relapsed classical Hodgkin lymphoma after autologous stem cell transplant;Blood;2016-01-21